Cargando…

Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations

Background and Study Objective: To estimate the prevalence of chronic edema (CO) and wounds within two vulnerable populations, a male high security prison in the East Midlands (United Kingdom) and residential and nursing homes in the United Kingdom and Australia. Methods and Results: Methods for scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moffatt, Christine J., Sykorova, Martina, Aubeeluck, Aimee, Franks, Peter John, Pankhurst, Sarah, Bussey, Rachel, Whiston, Siobhan, Murray, Susie, Mercier, Gregoire, Quéré, Isabelle, Gordon, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639103/
https://www.ncbi.nlm.nih.gov/pubmed/30995187
http://dx.doi.org/10.1089/lrb.2018.0083
_version_ 1783436403450839040
author Moffatt, Christine J.
Sykorova, Martina
Aubeeluck, Aimee
Franks, Peter John
Pankhurst, Sarah
Bussey, Rachel
Whiston, Siobhan
Murray, Susie
Mercier, Gregoire
Quéré, Isabelle
Gordon, Susan
author_facet Moffatt, Christine J.
Sykorova, Martina
Aubeeluck, Aimee
Franks, Peter John
Pankhurst, Sarah
Bussey, Rachel
Whiston, Siobhan
Murray, Susie
Mercier, Gregoire
Quéré, Isabelle
Gordon, Susan
author_sort Moffatt, Christine J.
collection PubMed
description Background and Study Objective: To estimate the prevalence of chronic edema (CO) and wounds within two vulnerable populations, a male high security prison in the East Midlands (United Kingdom) and residential and nursing homes in the United Kingdom and Australia. Methods and Results: Methods for screening for CO and wounds were adapted from the main LIMPRINT methodology. Prison Population: In total, 195 inmates were recruited with 22 (11%) having CO. While the majority were white Caucasian (156/83.4%) a further 20 (10.7%) were dark skinned with 11 (5.95%) from other minority populations. Comorbidities included 123 (63%) smokers, 22 (11%) alcohol dependant, 60 (31%) with mental health problems, and 35 (18%) a history of self-harm. Only three had a current wound with 30 (16%) having had a traumatic stab wound. Residential and Nursing Homes (United Kingdom and Australia): In the United Kingdom, the total population available for inclusion was 189 with only 137 (73%) recruited. Seventy-two of the 137 (52%) suffered from CO and a further 16 (23%) had a history of cellulitis. Results from the Australian residential care facilities have been published in full. In summary, of the 37 participants 20 (54%) experienced CO with 25 (68%) having comorbidities and 11 (30%) having a concurrent wound. Conclusion: Obtaining an accurate picture of the prevalence and impact of CO in vulnerable populations is extremely challenging due to issues of access and consent. Lack of reliable data for these populations will contribute to poor service provision.
format Online
Article
Text
id pubmed-6639103
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-66391032019-07-19 Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations Moffatt, Christine J. Sykorova, Martina Aubeeluck, Aimee Franks, Peter John Pankhurst, Sarah Bussey, Rachel Whiston, Siobhan Murray, Susie Mercier, Gregoire Quéré, Isabelle Gordon, Susan Lymphat Res Biol Original Articles Background and Study Objective: To estimate the prevalence of chronic edema (CO) and wounds within two vulnerable populations, a male high security prison in the East Midlands (United Kingdom) and residential and nursing homes in the United Kingdom and Australia. Methods and Results: Methods for screening for CO and wounds were adapted from the main LIMPRINT methodology. Prison Population: In total, 195 inmates were recruited with 22 (11%) having CO. While the majority were white Caucasian (156/83.4%) a further 20 (10.7%) were dark skinned with 11 (5.95%) from other minority populations. Comorbidities included 123 (63%) smokers, 22 (11%) alcohol dependant, 60 (31%) with mental health problems, and 35 (18%) a history of self-harm. Only three had a current wound with 30 (16%) having had a traumatic stab wound. Residential and Nursing Homes (United Kingdom and Australia): In the United Kingdom, the total population available for inclusion was 189 with only 137 (73%) recruited. Seventy-two of the 137 (52%) suffered from CO and a further 16 (23%) had a history of cellulitis. Results from the Australian residential care facilities have been published in full. In summary, of the 37 participants 20 (54%) experienced CO with 25 (68%) having comorbidities and 11 (30%) having a concurrent wound. Conclusion: Obtaining an accurate picture of the prevalence and impact of CO in vulnerable populations is extremely challenging due to issues of access and consent. Lack of reliable data for these populations will contribute to poor service provision. Mary Ann Liebert, Inc., publishers 2019-04-01 2019-04-22 /pmc/articles/PMC6639103/ /pubmed/30995187 http://dx.doi.org/10.1089/lrb.2018.0083 Text en © Christine J. Moffatt et al. 2019; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Moffatt, Christine J.
Sykorova, Martina
Aubeeluck, Aimee
Franks, Peter John
Pankhurst, Sarah
Bussey, Rachel
Whiston, Siobhan
Murray, Susie
Mercier, Gregoire
Quéré, Isabelle
Gordon, Susan
Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations
title Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations
title_full Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations
title_fullStr Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations
title_full_unstemmed Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations
title_short Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations
title_sort clinical and ethical challenges in undertaking limprint in vulnerable populations
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639103/
https://www.ncbi.nlm.nih.gov/pubmed/30995187
http://dx.doi.org/10.1089/lrb.2018.0083
work_keys_str_mv AT moffattchristinej clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT sykorovamartina clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT aubeeluckaimee clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT frankspeterjohn clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT pankhurstsarah clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT busseyrachel clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT whistonsiobhan clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT murraysusie clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT merciergregoire clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT quereisabelle clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations
AT gordonsusan clinicalandethicalchallengesinundertakinglimprintinvulnerablepopulations